← Back
$CORT All transactions

CORCEPT THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$0

Shares

5,823

Price

$0

Filed

Aug 5

Insider

Name

Lyon Joseph Douglas

Title

See Remarks

CIK

0001817838

Roles

Officer

Transaction Details

Transaction Date

2025-08-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

31,571

Footnotes

Includes 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. | The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 30, 2024 in effect at the time of this transaction. | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $67.24 to $67.945 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. | Fully exercisable.

Filing Info

Accession No.

0000950170-25-103319

Form Type

4

Issuer CIK

0001088856

Lyon Joseph Douglas's History

Date Ticker Type Value
2025-12-02 CORT F $9K
2025-12-01 CORT M $68K
2025-12-01 CORT $398K
2025-12-01 CORT A $14K
2025-12-01 CORT A $0
2025-12-01 CORT M $0
2025-11-03 CORT M $68K
2025-11-03 CORT $368K
2025-11-03 CORT M $0
2025-10-01 CORT M $68K

Other Insiders at CORT (90d)

Insider Bought Sold Last
BAKER G LEONARD JR 2026-01-27
WILSON JAMES N 2026-04-06
BELANOFF JOSEPH K
Chief Executive Officer
$1.3M 2026-03-25
Hunt Hazel
Chief Scientific Officer
2026-02-09
Guyer William
Chief Development Officer
$2.1M 2026-04-07